menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Hypoactive Sexual Desire Disorder: The Impact on the Midlife Woman

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder for women of all ages, but it is also one of the most difficult to address. Clinicians need to understand the implications and address the concerns of their patients. Host Dr. Prathima Setty discusses this topic with Sheryl A. Kingsberg, PhD, Chief, Division of Behavioral Medicine, Department of Obstetrics/Gynecology, University Hospitals Case Medical Center, and Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University, Cleveland, OH.

    About NAMS

    The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder for women of all ages, but it is also one of the most difficult to address. Clinicians need to understand the implications and address the concerns of their patients. Host Dr. Prathima Setty discusses this topic with Sheryl A. Kingsberg, PhD, Chief, Division of Behavioral Medicine, Department of Obstetrics/Gynecology, University Hospitals Case Medical Center, and Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University, Cleveland, OH.

    About NAMS

    The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.

     

Facebook Comments

Schedule24 Apr 2024